%0 Journal Article
%T Anorectal Gastrointestinal Stromal Tumor: A Case Report and Literature Review
%A Sanjeev Singhal
%A Anu Singhal
%A Rahul Tugnait
%A Vineet Varghese
%A Bishwanath Tiwari
%A Pankaj K. Arora
%A Pawan Malik
%A Mriganka Deuri Bharali
%A Ankur Subhash Dhuria
%A Pushkar Chauhan
%A Chandrakant Singh
%A Amit Ballani
%A Vishnu Panwar
%J Case Reports in Gastrointestinal Medicine
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/934875
%X Gastrointestinal stromal tumors or ¡°GIST¡± are mesenchymal neoplasms expressing KIT(CD117) tyrosine kinase and showing the presence of activating mutations in KIT or PDGFR¦Á (platelet-derived growth factor alpha). GIST of anal canal is an extremely rare tumor, accounting for only 3% of all anorectal mesenchymal tumors and 0.1¨C0.4% of all GIST. GIST with large tumor size and high mitotic activity are highly malignant, but the biological behavior of anorectal GIST is less clear. Abdominoperineal resection (APR) or conservative surgery is the best treatment option. Imatinib mesylate, a tyrosine kinase inhibitor, has shown promising results in its management. We present a case of anorectal GIST diagnosed by computed tomography (CT) scan, magnetic resonance imaging (MRI), and colonoscopy with biopsy. The patient underwent abdominoperineal resection (APR) and was confirmed on histopathology to have anal canal GIST with tumor size more than 5£¿cm in maximum dimension and mitotic figures more than 5/50 high power field (HPF). The CD117¡ªimmunoreactive score¡ªwas 3+ in spindled cells. Therefore the patient was put on adjuvant imatinib mesylate 400£¿mg daily. 1. Introduction Gastrointestinal stromal tumor or ¡°GIST¡± was a name given in 1983 to a group of gastrointestinal tumors which were otherwise unclassifiable as being of smooth muscle or neurogenic origin [1]. They are mesenchymal neoplasms expressing KIT(CD117) tyrosine kinase and showing presence of activating mutations in KIT or PDGFR¦Á (platelet-derived growth factor alpha) [2]. It is the commonest gastrointestinal mesenchymal tumor [3] with the commonest site being stomach (50¨C60%), followed by small intestine (30¨C40%), colon (7%), and oesophagus (1%) [4]. GIST of anal canal and rectum are often grouped together and account for nearly 5% of all GIST [4, 5]. However, of these only 2¨C8% are from anal canal, making GIST of anal canal an extremely rare tumor [6, 7]. 2. Case Report A 61-year-old male presented with pain during defecation and occasional bleeding per rectum over 2 months. Pain was nonradiating, dull aching, and persistent. Pain increased with constipation. Bleeding was frank red and came as drops after passage of stool. There was no tenesmus. There was no dizziness, weakness, pica, or weight loss. There was no significant relief with medication. The patient was not a known case of piles/diabetes mellitus/hypertension/tuberculosis/or any other chronic ailment. The patient was a known alcoholic and smoker. He had no urinary complaints. There were no other complaints referable to chest and cardiac or
%U http://www.hindawi.com/journals/crigm/2013/934875/